169 related articles for article (PubMed ID: 28796076)
41. Cannabis use may reduce healthcare utilization and improve hospital outcomes in patients with cirrhosis.
Sobotka LA; Mumtaz K; Hinton A; Kelly SG; Conteh LF; Michaels AJ; Hanje AJ; Wellner MR
Ann Hepatol; 2021; 23():100280. PubMed ID: 33157269
[TBL] [Abstract][Full Text] [Related]
42. Hyponatremia-associated healthcare burden among US patients hospitalized for cirrhosis.
Deitelzweig S; Amin A; Christian R; Friend K; Lin J; Lowe TJ
Adv Ther; 2013 Jan; 30(1):71-80. PubMed ID: 23292659
[TBL] [Abstract][Full Text] [Related]
43. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
44. In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009.
Stepanova M; Mishra A; Venkatesan C; Younossi ZM
Clin Gastroenterol Hepatol; 2012 Sep; 10(9):1034-41.e1. PubMed ID: 22642955
[TBL] [Abstract][Full Text] [Related]
45. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.
Arroyo V; Jiménez W
J Hepatol; 2000; 32(1 Suppl):157-70. PubMed ID: 10728802
[TBL] [Abstract][Full Text] [Related]
46. Mortality from Spontaneous Bacterial Peritonitis Among Hospitalized Patients in the USA.
Niu B; Kim B; Limketkai BN; Sun J; Li Z; Woreta T; Chen PH
Dig Dis Sci; 2018 May; 63(5):1327-1333. PubMed ID: 29480417
[TBL] [Abstract][Full Text] [Related]
47. Timely Albumin Infusion May Improve Resource Utilization in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis.
Kim WR; Raghunathan K; Martin GS; Davis EA; Sindhwani NS; Telang S; Lodaya K
Biomed Res Int; 2024; 2024():6673823. PubMed ID: 38899040
[TBL] [Abstract][Full Text] [Related]
48. Length of stay, hospitalization cost, and in-hospital mortality in US adult inpatients with immune thrombocytopenic purpura, 2006-2012.
An R; Wang PP
Vasc Health Risk Manag; 2017; 13():15-21. PubMed ID: 28176930
[TBL] [Abstract][Full Text] [Related]
49. MELD score and albumin replacement are related to higher costs during management of patients with refractory ascites.
Borges de Santana V; Bertocco de Paiva Haddad L; Morgado Conte T; Cortez Rizzon A; Miranda Barbosa V; Shield W; Andraus W; Augusto Carneiro D'Albuquerque L
Transplant Proc; 2014; 46(6):1760-3. PubMed ID: 25131030
[TBL] [Abstract][Full Text] [Related]
50. Burden of adult pneumonia in Thailand: a nationwide hospital admission data 2010.
Reechaipichitkul W; Thavornpitak Y; Sutra S
J Med Assoc Thai; 2014 Mar; 97(3):283-92. PubMed ID: 25123007
[TBL] [Abstract][Full Text] [Related]
51. Frequency of Complications Including Death from Coronary Artery Bypass Grafting in Patients With Hepatic Cirrhosis.
Singh V; Savani GT; Mendirichaga R; Jonnalagadda AK; Cohen MG; Palacios IF
Am J Cardiol; 2018 Dec; 122(11):1853-1861. PubMed ID: 30293650
[TBL] [Abstract][Full Text] [Related]
52. Trends and outcomes of peptic ulcer disease in patients with cirrhosis.
Shah H; Yang TJ; Wudexi I; Solanki S; Patel S; Rajan D; Rodas A; Dajjani M; Chakinala RC; Shah P; Sarker K; Patel A; Aronow W
Postgrad Med; 2020 Nov; 132(8):773-780. PubMed ID: 32654578
[TBL] [Abstract][Full Text] [Related]
53. Assessing the risk of decompensation by ascites and spontaneous bacterial peritonitis in cirrhosis.
Dănulescu RM; Stanciu C; Trifan A
Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):320-6. PubMed ID: 25076694
[TBL] [Abstract][Full Text] [Related]
54. Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis.
De Roza MA; Kai L; Kam JW; Chan YH; Kwek A; Ang TL; Hsiang JC
World J Gastroenterol; 2019 Sep; 25(33):4933-4944. PubMed ID: 31543684
[TBL] [Abstract][Full Text] [Related]
55. Clostridium difficile is associated with poor outcomes in patients with cirrhosis: A national and tertiary center perspective.
Bajaj JS; Ananthakrishnan AN; Hafeezullah M; Zadvornova Y; Dye A; McGinley EL; Saeian K; Heuman D; Sanyal AJ; Hoffmann RG
Am J Gastroenterol; 2010 Jan; 105(1):106-13. PubMed ID: 19844204
[TBL] [Abstract][Full Text] [Related]
56. Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites.
Di Pascoli M; Fasolato S; Piano S; Bolognesi M; Angeli P
Liver Int; 2019 Jan; 39(1):98-105. PubMed ID: 30230204
[TBL] [Abstract][Full Text] [Related]
57. Clinical course and short-term mortality of cirrhotic patients with infections other than spontaneous bacterial peritonitis.
Fernández J; Acevedo J; Prado V; Mercado M; Castro M; Pavesi M; Arteaga M; Sastre L; Juanola A; Ginès P; Arroyo V
Liver Int; 2017 Mar; 37(3):385-395. PubMed ID: 27558198
[TBL] [Abstract][Full Text] [Related]
58. Hospital resource intensity and cirrhosis mortality in United States.
Mathur AK; Chakrabarti AK; Mellinger JL; Volk ML; Day R; Singer AL; Hewitt WR; Reddy KS; Moss AA
World J Gastroenterol; 2017 Mar; 23(10):1857-1865. PubMed ID: 28348492
[TBL] [Abstract][Full Text] [Related]
59. Effect of Admission Time on the Outcomes of Liver Cirrhosis with Acute Upper Gastrointestinal Bleeding: Regular Hours versus Off-Hours Admission.
Li Y; Han B; Li H; Song T; Bao W; Wang R; Bai Z; Zheng K; Li Q; Guo X; Qi X
Can J Gastroenterol Hepatol; 2018; 2018():3541365. PubMed ID: 30631756
[TBL] [Abstract][Full Text] [Related]
60. Management of ascites in cirrhosis.
Sandhu BS; Sanyal AJ
Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
